Companies in this industry face slightly different security challenges as compared to traditional manufacturing companies

Threat of Insiders

One of the biggest threats to the pharmaceutical industry is not from a hacker, but from someone inside the organization such as an employee or contractor. Insiders are a problem because they are trusted to handle information within the company and based on their position, they could have access to sensitive information. Dealing with malicious, disgruntled or ignorant insiders is much more difficult than dealing with outsiders.

Valuable Patient Information

Patient data is abundant in the pharmaceutical industry. Patient data is collected from employees, clinical patients and donors. Patient health information is very valuable because the records tell a person’s entire life history as well as transactional history. This potentially exposes the company to health, financial and reputational risk.

Supply Chain Security

A number of business processes, which require pharma companies to share confidential information with third parties, make them vulnerable to information security breaches – Increased number of licensing deals and collaborations – Increased outsourcing of manufacturing and clinical trials to third parties – Increased usage of social media and other technologies for information exchange and communication.

IP Protection

Nothing is more valuable to a pharmaceutical company than the formula for its new drugs. The value of stealing a potentially successful drug design, particularly one not protected yet, is huge. IP theft offers the unethical competitor the opportunity to bypass the risk and cost of R&D and take a short cut to marketing a profitable drug. With a global manufacturing base and worldwide market, exploitation of stolen pharmaceutical industry is fairly straightforward—more so than in industries where complex, technologically intensive manufacturing processes reduce the pool of partners in a position to exploit stolen IP

Compliance Regulations

National and international regulations have become active to provide the first line of defense against security threats, making compliance to voluntary standards, as well as government mandates, a cornerstone. Several countries have come up with regulations. South Asian facilities from India need to follow National Good Laboratory Practice (GLP) Compliance Monitoring Authority, Department of Science and Technology. Since many pharma companies span multiple borders, they should also abide by national regulations within each operating region.

Sequretek Solutions